PAM(PAM)
PAM
Q4 2026 EPS Estimate
$2.15
Nov 2, 2026 · Reports after close
Revenue Estimate
$780M
FY2026E EPS$9.81
FY2027E EPS$11.07
Analyst Sentiment
Wall St. Consensus
Buy7 analysts·Limited coverage
64
Score
4 Buy (57%)3 Hold (43%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
457%
Hold
343%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$97.00
+21.5%
Consensus
$97.00
+21.5%
Bull
$97.00
+21.5%
12-Month Target Range7 analysts
$97.00$97.00$97.00
Current $79.85Consensus
Current Price
$79.85
Upside to Consensus
$17.15
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+16.82%
EPS+12.91%
FY2028
Rev+12.39%
EPS+11.71%
FY2029
Rev-19.00%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $2.60B | $3.04B | $3.41B | $2.76B |
| Low | $2.48B | $2.70B | $2.87B | $2.33B |
| High | $2.71B | $3.38B | $3.75B | $3.04B |
| EBITDA Avg | $1.71B | $1.99B | $2.24B | $1.82B |
| Low | $1.63B | $1.78B | $1.89B | $1.53B |
| High | $1.78B | $2.22B | $2.46B | $2.00B |
| EBIT Avg | $1.10B | $1.29B | $1.45B | $1.17B |
| Low | $1.06B | $1.15B | $1.22B | $988M |
| High | $1.15B | $1.43B | $1.59B | $1.29B |
| Net Income Avg | $533M | $602M | $673M | — |
| Low | $491M | $480M | $534M | — |
| High | $574M | $671M | $759M | — |
| EPS Avg | $9.81 | $11.07 | $12.37 | — |
| Low | $9.03 | $8.82 | $9.82 | — |
| High | $10.56 | $12.34 | $13.96 | — |
| Analysts (Rev / EPS) | 6 / 6 | 6 / 6 | 2 / 3 | 4 / 3 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $780M | $659M | $754M | $756M | $759M | $761M |
| Low | $728M | $604M | $711M | $713M | $716M | $718M |
| High | $832M | $714M | $797M | $799M | $802M | $805M |
| EBITDA Avg | $513M | $433M | $495M | $497M | $499M | $500M |
| Low | $479M | $397M | $467M | $469M | $470M | $472M |
| High | $547M | $470M | $524M | $525M | $527M | $529M |
| EBIT Avg | $332M | $280M | $320M | $321M | $323M | $324M |
| Low | $309M | $257M | $302M | $303M | $304M | $305M |
| High | $354M | $304M | $339M | $340M | $341M | $342M |
| Net Income Avg | $137M | $89M | $88M | $125M | $126M | $114M |
| Low | $115M | $75M | $82M | $116M | $117M | $106M |
| High | $159M | $103M | $95M | $134M | $135M | $123M |
| EPS Avg | $2.56 | $1.67 | $1.65 | $2.33 | $2.35 | $2.13 |
| Low | $2.14 | $1.40 | $1.53 | $2.16 | $2.18 | $1.97 |
| High | $2.97 | $1.93 | $1.77 | $2.50 | $2.52 | $2.29 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |